Lantheus Holdings Inc (LNTH)
90.52
+3.20
(+3.66%)
USD |
NASDAQ |
Nov 22, 16:00
90.55
+0.03
(+0.03%)
After-Hours: 20:00
Lantheus Holdings Enterprise Value: 5.993B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 5.993B |
| November 21, 2024 | 5.770B |
| November 20, 2024 | 5.710B |
| November 19, 2024 | 5.221B |
| November 18, 2024 | 4.998B |
| November 15, 2024 | 5.041B |
| November 14, 2024 | 5.319B |
| November 13, 2024 | 5.244B |
| November 12, 2024 | 5.619B |
| November 11, 2024 | 5.545B |
| November 08, 2024 | 5.783B |
| November 07, 2024 | 5.839B |
| November 06, 2024 | 6.038B |
| November 05, 2024 | 7.692B |
| November 04, 2024 | 7.726B |
| November 01, 2024 | 7.206B |
| October 31, 2024 | 7.336B |
| October 30, 2024 | 7.304B |
| October 29, 2024 | 7.352B |
| October 28, 2024 | 7.353B |
| October 25, 2024 | 7.366B |
| October 24, 2024 | 7.332B |
| October 23, 2024 | 7.390B |
| October 22, 2024 | 7.528B |
| October 21, 2024 | 7.490B |
| Date | Value |
|---|---|
| October 18, 2024 | 7.811B |
| October 17, 2024 | 7.738B |
| October 16, 2024 | 7.519B |
| October 15, 2024 | 7.482B |
| October 14, 2024 | 7.396B |
| October 11, 2024 | 7.498B |
| October 10, 2024 | 7.218B |
| October 09, 2024 | 7.295B |
| October 08, 2024 | 7.214B |
| October 07, 2024 | 7.109B |
| October 04, 2024 | 7.192B |
| October 03, 2024 | 7.106B |
| October 02, 2024 | 7.011B |
| October 01, 2024 | 7.056B |
| September 30, 2024 | 7.328B |
| September 27, 2024 | 7.261B |
| September 26, 2024 | 7.058B |
| September 25, 2024 | 7.302B |
| September 24, 2024 | 7.567B |
| September 23, 2024 | 7.539B |
| September 20, 2024 | 7.448B |
| September 19, 2024 | 7.344B |
| September 18, 2024 | 7.315B |
| September 17, 2024 | 7.135B |
| September 16, 2024 | 7.272B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
462.97M
Minimum
Mar 18 2020
8.388B
Maximum
Jul 11 2024
3.373B
Average
3.712B
Median
Feb 14 2024
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -31.63M |
| Pulmonx Corp | 197.58M |
| RxSight Inc | 1.570B |
| PROCEPT BioRobotics Corp | 4.919B |
| Electromed Inc | 238.10M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 131.09M |
| Revenue (Quarterly) | 378.73M |
| Total Expenses (Quarterly) | 244.99M |
| EPS Diluted (Quarterly) | 1.79 |
| Gross Profit Margin (Quarterly) | 63.93% |
| Profit Margin (Quarterly) | 34.61% |
| Earnings Yield | 6.64% |
| Operating Earnings Yield | 7.38% |
| Normalized Earnings Yield | 5.693 |